Clinical Trial Update: Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intraperitoneal insulin administration to subcutaneous insulin administration in Type 1 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2011-06-23